BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 29232514)

  • 1. Discovery of Novel Selective Acetyl-CoA Carboxylase (ACC) 1 Inhibitors.
    Mizojiri R; Asano M; Tomita D; Banno H; Nii N; Sasaki M; Sumi H; Satoh Y; Yamamoto Y; Moriya T; Satomi Y; Maezaki H
    J Med Chem; 2018 Feb; 61(3):1098-1117. PubMed ID: 29232514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and synthesis of a novel 1H-pyrrolo[3,2-b]pyridine-3-carboxamide derivative as an orally available ACC1 inhibitor.
    Mizojiri R; Nii N; Asano M; Sasaki M; Satoh Y; Yamamoto Y; Sumi H; Maezaki H
    Bioorg Med Chem; 2019 Jun; 27(12):2521-2530. PubMed ID: 30879862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and synthesis of a monocyclic derivative as a selective ACC1 inhibitor by chemical modification of biphenyl ACC1/2 dual inhibitors.
    Mizojiri R; Tomita D; Sasaki M; Satoh Y; Yamamoto Y; Sumi H; Maezaki H
    Bioorg Med Chem; 2021 Apr; 35():116056. PubMed ID: 33607488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The identification and pharmacological evaluation of potent, selective and orally available ACC1 inhibitor.
    Mizojiri R; Asano M; Sasaki M; Satoh Y; Yamamoto Y; Sumi H; Maezaki H
    Bioorg Med Chem Lett; 2019 Dec; 29(23):126749. PubMed ID: 31672259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of a novel olefin derivative as a highly potent and selective acetyl-CoA carboxylase 2 inhibitor with in vivo efficacy.
    Nishiura Y; Matsumura A; Kobayashi N; Shimazaki A; Sakamoto S; Kitade N; Tonomura Y; Ino A; Okuno T
    Bioorg Med Chem Lett; 2018 Aug; 28(14):2498-2503. PubMed ID: 29903660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis and biological evaluation of novel spiro-pentacylamides as acetyl-CoA carboxylase inhibitors.
    Wei Q; Mei L; Yang Y; Ma H; Chen H; Zhang H; Zhou J
    Bioorg Med Chem; 2018 Aug; 26(14):3866-3874. PubMed ID: 30049586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis and biological evaluation of novel chroman derivatives as non-selective acetyl-CoA carboxylase inhibitors.
    Wei Q; Mei L; Chen P; Yuan X; Zhang H; Zhou J
    Bioorg Chem; 2020 Aug; 101():103943. PubMed ID: 32554277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-activity relationships for a novel series of thiazolyl phenyl ether derivatives exhibiting potent and selective acetyl-CoA carboxylase 2 inhibitory activity.
    Clark RF; Zhang T; Xin Z; Liu G; Wang Y; Hansen TM; Wang X; Wang R; Zhang X; Frevert EU; Camp HS; Beutel BA; Sham HL; Gu YG
    Bioorg Med Chem Lett; 2006 Dec; 16(23):6078-81. PubMed ID: 16973360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and anti-cancer activity of ND-646 and its derivatives as acetyl-CoA carboxylase 1 inhibitors.
    Li EQ; Zhao W; Zhang C; Qin LZ; Liu SJ; Feng ZQ; Wen X; Chen CP
    Eur J Pharm Sci; 2019 Sep; 137():105010. PubMed ID: 31325544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design of small molecule inhibitors of acetyl-CoA carboxylase 1 and 2 showing reduction of hepatic malonyl-CoA levels in vivo in obese Zucker rats.
    Bengtsson C; Blaho S; Saitton DB; Brickmann K; Broddefalk J; Davidsson O; Drmota T; Folmer R; Hallberg K; Hallén S; Hovland R; Isin E; Johannesson P; Kull B; Larsson LO; Löfgren L; Nilsson KE; Noeske T; Oakes N; Plowright AT; Schnecke V; Ståhlberg P; Sörme P; Wan H; Wellner E; Oster L
    Bioorg Med Chem; 2011 May; 19(10):3039-53. PubMed ID: 21515056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and biological evaluation of 4-phenoxy-phenyl isoxazoles as novel acetyl-CoA carboxylase inhibitors.
    Wu X; Yu Y; Huang T
    J Enzyme Inhib Med Chem; 2021 Dec; 36(1):1236-1247. PubMed ID: 34100310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. (4-Piperidinyl)-piperazine: a new platform for acetyl-CoA carboxylase inhibitors.
    Chonan T; Oi T; Yamamoto D; Yashiro M; Wakasugi D; Tanaka H; Ohoka-Sugita A; Io F; Koretsune H; Hiratate A
    Bioorg Med Chem Lett; 2009 Dec; 19(23):6645-8. PubMed ID: 19853443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of spirocyclic-diamine inhibitors of mammalian acetyl CoA-carboxylase.
    Kung DW; Griffith DA; Esler WP; Vajdos FF; Mathiowetz AM; Doran SD; Amor PA; Bagley SW; Banks T; Cabral S; Ford K; Garcia-Irizarry CN; Landis MS; Loomis K; McPherson K; Niosi M; Rockwell KL; Rose C; Smith AC; Southers JA; Tapley S; Tu M; Valentine JJ
    Bioorg Med Chem Lett; 2015 Nov; 25(22):5352-6. PubMed ID: 26411795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Symmetrical approach of spiro-pyrazolidinediones as acetyl-CoA carboxylase inhibitors.
    Kamata M; Yamashita T; Kina A; Tawada M; Endo S; Mizukami A; Sasaki M; Tani A; Nakano Y; Watanabe Y; Furuyama N; Funami M; Amano N; Fukatsu K
    Bioorg Med Chem Lett; 2012 Jul; 22(14):4769-72. PubMed ID: 22677317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, Biological Evaluation and Molecular Docking Studies of Piperidinylpiperidines and Spirochromanones Possessing Quinoline Moieties as Acetyl-CoA Carboxylase Inhibitors.
    Huang T; Sun J; Wang Q; Gao J; Liu Y
    Molecules; 2015 Sep; 20(9):16221-34. PubMed ID: 26370948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acetyl-CoA carboxylase inhibition by ND-630 reduces hepatic steatosis, improves insulin sensitivity, and modulates dyslipidemia in rats.
    Harriman G; Greenwood J; Bhat S; Huang X; Wang R; Paul D; Tong L; Saha AK; Westlin WF; Kapeller R; Harwood HJ
    Proc Natl Acad Sci U S A; 2016 Mar; 113(13):E1796-805. PubMed ID: 26976583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mislocalization and inhibition of acetyl-CoA carboxylase 1 by a synthetic small molecule.
    Jung D; Abu-Elheiga L; Ayuzawa R; Gu Z; Shirakawa T; Fujiki Y; Nakatsuji N; Wakil SJ; Uesugi M
    Biochem J; 2012 Dec; 448(3):409-16. PubMed ID: 23067267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and structure-activity relationships of N-{3-[2-(4-alkoxyphenoxy)thiazol-5-yl]-1- methylprop-2-ynyl}carboxy derivatives as selective acetyl-CoA carboxylase 2 inhibitors.
    Gu YG; Weitzberg M; Clark RF; Xu X; Li Q; Zhang T; Hansen TM; Liu G; Xin Z; Wang X; Wang R; McNally T; Zinker BA; Frevert EU; Camp HS; Beutel BA; Sham HL
    J Med Chem; 2006 Jun; 49(13):3770-3. PubMed ID: 16789734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potent biphenyl- and 3-phenyl pyridine-based inhibitors of acetyl-CoA carboxylase.
    Haque TS; Liang N; Golla R; Seethala R; Ma Z; Ewing WR; Cooper CB; Pelleymounter MA; Poss MA; Cheng D
    Bioorg Med Chem Lett; 2009 Oct; 19(20):5872-6. PubMed ID: 19740659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Piperazine oxadiazole inhibitors of acetyl-CoA carboxylase.
    Bourbeau MP; Siegmund A; Allen JG; Shu H; Fotsch C; Bartberger MD; Kim KW; Komorowski R; Graham M; Busby J; Wang M; Meyer J; Xu Y; Salyers K; Fielden M; Véniant MM; Gu W
    J Med Chem; 2013 Dec; 56(24):10132-41. PubMed ID: 24294923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.